Matching articles for "Fluzone Intradermal"

Influenza Vaccine for 2017-2018

   
The Medical Letter on Drugs and Therapeutics • October 9, 2017;  (Issue 1531)
Routine annual vaccination against influenza A and B viruses is recommended for everyone ≥6 months old without a specific...
Routine annual vaccination against influenza A and B viruses is recommended for everyone ≥6 months old without a specific contraindication.
Med Lett Drugs Ther. 2017 Oct 9;59(1531):163-6 | Show Full IntroductionHide Full Introduction

Influenza Vaccine for 2016-2017

   
The Medical Letter on Drugs and Therapeutics • October 10, 2016;  (Issue 1505)
Annual vaccination against influenza A and B viruses is recommended for everyone ≥6 months old without a specific...
Annual vaccination against influenza A and B viruses is recommended for everyone ≥6 months old without a specific contraindication.
Med Lett Drugs Ther. 2016 Oct 10;58(1505):127-30 | Show Full IntroductionHide Full Introduction

Influenza Vaccine for 2015-2016

   
The Medical Letter on Drugs and Therapeutics • September 14, 2015;  (Issue 1477)
Annual vaccination against influenza A and B viruses is recommended for everyone ≥6 months old without a specific...
Annual vaccination against influenza A and B viruses is recommended for everyone ≥6 months old without a specific contraindication.
Med Lett Drugs Ther. 2015 Sep 14;57(1477):125-7 | Show Full IntroductionHide Full Introduction

Influenza Vaccine for 2014-2015

   
The Medical Letter on Drugs and Therapeutics • October 13, 2014;  (Issue 1453)
Annual vaccination against influenza A and B viruses has been shown to decrease influenza illness and...
Annual vaccination against influenza A and B viruses has been shown to decrease influenza illness and its complications.
Med Lett Drugs Ther. 2014 Oct 13;56(1453):97-9 | Show Full IntroductionHide Full Introduction

Adult Immunization

   
The Medical Letter on Drugs and Therapeutics • June 1, 2014;  (Issue 142)
Vaccines recommended for adults residing in the US are reviewed here. Vaccines for travel have been reviewed separately. Eight vaccines are currently recommended by the US Advisory Committee on...
Vaccines recommended for adults residing in the US are reviewed here. Vaccines for travel have been reviewed separately.

Eight vaccines are currently recommended by the US Advisory Committee on Immunization Practices (ACIP) for routine use in adults at various ages...
Treat Guidel Med Lett. 2014 Jun;12(142):39-48 | Show Full IntroductionHide Full Introduction

Influenza Vaccine for 2013-2014

   
The Medical Letter on Drugs and Therapeutics • September 16, 2013;  (Issue 1425)
Annual vaccination against influenza A and B viruses has been shown to decrease influenza illness and its complications. Several new vaccines are available for the current...
Annual vaccination against influenza A and B viruses has been shown to decrease influenza illness and its complications. Several new vaccines are available for the current season.
Med Lett Drugs Ther. 2013 Sep 16;55(1425):73-5 | Show Full IntroductionHide Full Introduction

Adult Immunizations

   
The Medical Letter on Drugs and Therapeutics • December 1, 2011;  (Issue 112)
Vaccines recommended for routine use in US adults are reviewed here. Vaccines for travel have been reviewed...
Vaccines recommended for routine use in US adults are reviewed here. Vaccines for travel have been reviewed separately.
Treat Guidel Med Lett. 2011 Dec;9(112):75-82 | Show Full IntroductionHide Full Introduction

Influenza Vaccine for 2011-2012

   
The Medical Letter on Drugs and Therapeutics • October 17, 2011;  (Issue 1375)
Annual vaccination against influenza A and B viruses is the most effective method of preventing influenza and has been shown to decrease influenza illness and complications. For the current season, a...
Annual vaccination against influenza A and B viruses is the most effective method of preventing influenza and has been shown to decrease influenza illness and complications. For the current season, a new inactivated intradermal vaccine (Fluzone Intradermal) has been FDA-approved for use in adults 18-64 years old. An upcoming issue will review chemoprophylaxis and treatment of influenza.
Med Lett Drugs Ther. 2011 Oct 17;53(1375):81-3 | Show Full IntroductionHide Full Introduction